Multimodality treatment by FOLFOX plus HIFU in a case of advanced pancreatic carcinoma. A case report.

Context: Pancreatic cancer is one of the most aggressive malignant diseases in which the survival rate has not improved in the past 40 years.

Case Report: A fifty-one-year-old male patient with inoperable metastatic pancreatic cancer and low response to chemotherapy with gemcitabine as single therapy underwent palliative high intensity focused ultrasound (HIFU) ablation. Continuing chemotherapy with folinic acid, oxaliplatin and 5-fluorouracil (FOLFOX) was made.